Ocular Surface Disease

Advanced imaging tools can be incorporated into clinical trials for OSD for enhanced care

Incorporating advanced imaging tools into interventional clinical trials for ocular surface diseases (OSDs) has “potential” to improve diagnostic capabilities. The findings were presented at the 2024 ARVO Annual Meeting in Seattle, Washington. The study focused on the presentation and demonstration of the following advanced imaging modalities in randomized clinical trials...